5 research outputs found

    The Effects of Supplementary Cementitious Materials (SCMs) on the Residual Mechanical Properties of Concrete after Exposure to High Temperatures—Review

    No full text
    Fire events remain a severe hazard despite significant progress in the construction industry. The high-temperature resistance of concrete structures highly depends on the properties of their ingredients. The present study provides an analytical review of the available experimental studies investigating the influence of high temperatures on the residual mechanical characteristics of concrete, namely compressive and tensile strength, as well as the modulus of elasticity. This paper primarily focuses on the influences of supplementary cementing materials, including silica fume (SF), fly ash (FA), and ground granulated blast furnace slag (GGBFS), as well as different aggregate types. The literature findings show that the mechanical characteristics of concrete are degraded dramatically due to heat-caused changes in concrete. In addition, the mechanical properties of concrete are highly influenced by the types of aggregate and the amount of supplementary cementing materials at both high temperatures and room temperature. The inclusion of FA and GGBFS improves the high-temperature resistance of concrete. However, high contents of FA and GGBFS result in adverse effects on the properties of concrete. This review will provide a basis for future studies and enhance the knowledge of the behaviour of reinforced concrete structures subjected to high temperatures

    Successful use of calcium channel blocker for management of arterio-venous malformations following Fontan procedure.

    Full text link
    In diffuse forms of arteriovenous malformation following Fontan procedure, "classical" medical therapy, inhaled nitric oxide and sildenafil, may play a role, until re-direction of hepatic flow to pulmonary circulation cures it. However, in refractory cases, as reported in our 2-year-old patient, unusual medications such as calcium channel blockers can be tried and continued if patients respond adequately
    corecore